Keyphrases
Indonesia
100%
Surabaya
56%
Tuberculosis Patients
52%
COVID-19
45%
Mycobacterium Tuberculosis (M. tb)
42%
Tuberculosis
39%
Pulmonary Tuberculosis
28%
Multidrug-resistant Tuberculosis (MDR-TB)
25%
Indonesian
17%
Gram-negative Bacteria
15%
Biofilm
15%
Rifampicin
14%
Risk Factors
13%
Neonatal Sepsis
13%
TB Patients
13%
Tertiary Referral Hospital
12%
Rifampicin-resistant Tuberculosis
11%
Xpert MTB
11%
East Java Indonesia
11%
Candida Albicans (C. albicans)
11%
Sputum
11%
In Vitro Study
10%
Passiflora Edulis Sims
10%
Biofilm Formation
10%
QTc Interval
10%
Inflammatory Cytokines
10%
Pseudomonas Aeruginosa (P. aeruginosa)
9%
Tuberculosis Diagnosis
9%
Healthcare Workers
9%
Quantitative PCR
8%
Referral Hospital
8%
Training Process
8%
AIDS/HIV
8%
Clinical Outcomes
8%
Moxifloxacin
8%
Type 1 Diabetes Mellitus (T1DM)
8%
General Hospital
8%
Interleukin-6
8%
Confidence Interval
7%
Custom Convolutional Neural Network
7%
Leukocytes
7%
Bedaquiline
7%
Hepatitis C Virus
7%
East Java
7%
Escherichia Coli
7%
HIV Patients
7%
Culture Method
7%
Red Passion Fruit
7%
Genotype
7%
Tuberculosis Treatment
7%
Rifampicin Resistance
7%
Tumor Necrosis Factor-α
7%
Interleukin-1β
7%
Sputum Samples
7%
Staphylococcus Aureus
6%
C-reactive Protein
6%
Pneumonia
6%
Antibiotic Resistance
6%
Polymicrobial Biofilm
6%
Blood Culture
6%
Acute Gastroenteritis
6%
Meropenem
6%
Lung Damage
6%
Inflammation
6%
Recombinant
6%
Xpert
6%
Data Augmentation
6%
Convolutional Neural Network
6%
Multidrug-resistant Organisms
6%
Acinetobacter Baumannii (A. baumannii)
5%
QT Prolongation
5%
High Prevalence
5%
Antibiotics
5%
Academic Hospital
5%
Protein Expression
5%
Antiviral Properties
5%
Candida Tropicalis
5%
Active Tuberculosis
5%
Methicillin Resistance
5%
Lactic Acid Bacteria
5%
Computation Time
5%
Peripheral Blood Mononuclear Cells
5%
Lymphocytes
5%
Lactobacillus Acidophilus
5%
Neutrophil-to-lymphocyte Ratio
5%
Latent Tuberculosis Infection
5%
Population Pharmacokinetic Model
5%
Jember
5%
Cloning Expression
5%
Hepatitis B Virus
5%
Potential Biomarkers
5%
Colorectal Cancer
5%
Fine-needle Aspiration Biopsy
5%
Synbiotics
5%
Cortisol
5%
Indonesian Patients
5%
Basidiobolomycosis
5%
Fluconazole
5%
Seroprevalence
5%
Cell-free
5%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
38%
Infection
29%
SARS Coronavirus
27%
Rifampicin
23%
Mycobacterium Tuberculosis
22%
Lung Tuberculosis
22%
Prevalence
21%
Drug Resistant Tuberculosis
17%
Pseudomonas aeruginosa
16%
Coronavirinae
14%
Infectious Agent
12%
Candida Albicans
11%
Antibiotics
11%
HIV
10%
Newborn Sepsis
10%
Tuberculosis
9%
Diabetes Mellitus
8%
Moxifloxacin
8%
Staphylococcus Aureus
8%
Bedaquiline
7%
Passiflora edulis
7%
Saussurea costus
7%
Hepatitis C Virus
7%
Antimicrobial Resistance
7%
Antivirus Agent
7%
Multi-Drug-Resistant Tuberculosis
7%
Acinetobacter Baumannii
7%
Cytokine
7%
Inflammation
6%
Escherichia coli
6%
Tumor Necrosis Factor
6%
Meropenem
6%
Acute Gastroenteritis
6%
Antiinfective Agent
6%
Retrospective Study
6%
Carbapenem
6%
Pharmacokinetics
6%
Biological Marker
5%
Immunoglobulin G Antibody
5%
Candida Tropicalis
5%
Gram Negative Bacterium
5%
Latent Tuberculosis
5%
Mortality Rate
5%
Sepsis
5%
Interleukin 6
5%
Cross-Sectional Study
5%
Treatment Group
5%
Mycobacteria
5%
Lung Injury
5%
Rotavirus
5%
Fluconazole
5%
Seroprevalence
5%
Pancreatic Lipase
5%
Extrapulmonary Tuberculosis
5%
Norovirus Infection
5%
Coffea Canephora
5%
Meticillin
5%